Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Change in Accured Expenses (2018 - 2025)

Entera Bio has reported Change in Accured Expenses over the past 8 years, most recently at $204000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses fell 34.62% year-over-year to $204000.0, compared with a TTM value of $1.0 million through Dec 2025, up 414.29%, and an annual FY2025 reading of $1.0 million, up 414.29% over the prior year.
  • Change in Accured Expenses came in at $204000.0 for Q4 2025, up from -$77000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $2.2 million in Q3 2021 to a low of -$808000.0 in Q1 2022.
  • Median Change in Accured Expenses over the past 5 years was $88500.0 (2021), compared with a mean of $224100.0.
  • The sharpest move saw Change in Accured Expenses tumbled 808.77% in 2022, then surged 3064.29% in 2025.
  • Over 5 years, Change in Accured Expenses stood at $1.1 million in 2021, then plummeted by 47.33% to $581000.0 in 2022, then crashed by 213.94% to -$662000.0 in 2023, then surged by 147.13% to $312000.0 in 2024, then tumbled by 34.62% to $204000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Change in Accured Expenses are $204000.0 (Q4 2025), -$77000.0 (Q3 2025), and $31000.0 (Q2 2025).